Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Yearbook of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.YONC.2012.07.027
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.

  2012cited by this paper
• Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children.

  2012cited by this paper

• Plasticity of Antioxidant Defense Pathways in Response to Aging and Cadmium in Glutathione-Deficient Mice

  2017cites this paper
• The use of biomarkers in detecting subclinical cardiotoxicity in doxorubicin-based treatment for paediatric patients with acute lymphoblastic leukaemia

  2017cites this paper
• Cardiotoxicity in oncology and coronary microcirculation: future challenges in theranostics.

  2017cites this paper
• Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview

  2017cites this paper
• Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant

  2017cites this paper
• Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia

  2017cites this paper
• Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancer

  2017cites this paper
• Outcome of anthracycline-related cardiomyopathy – experience of a cardiooncology clinic at a tertiary referral cancer centre

  2017cites this paper
• ZEBRAFISH XENOTRANSPLANTATION AS A PRECLINICAL THERAPEUTIC PLATFORM FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

  2016cites this paper
• CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.

  2016cites this paper
• Current views on anthracycline cardiotoxicity

  2016cites this paper
• Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients

  2015cites this paper
• Основные вехи в эволюции лечения пациентов с детским раком

  2015cites this paper
• Series ACUTE LYMPHOBLASTIC LEUKEMIA Inherited genetic variation in childhood acute lymphoblastic leukemia

  2015cites this paper
• ACUTE LYMPHOBLASTIC LEUKEMIA Inherited genetic variation in childhood acute lymphoblastic leukemia

  2015cites this paper
• Can pharmacogenomics help to improve therapy in patients with high-grade osteosarcoma?

  2015cites this paper
• Novel imaging methods and biomarkers in the screening of late cardiac effects after childhood cancer

  2015cites this paper
• Collaborative Research in Childhood Cancer Survivorship: The Current Landscape.

  2015cites this paper
• Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial.

  2014cites this paper
• Interindividual Variability in the Cardiac Expression of Anthracycline Reductases in Donors With and Without Down Syndrome

  2014cites this paper
• Express ion of Anthracyc l ine Reductases in Donors With and Without Down Syndrome

  2014cites this paper
• Imaging of early modification in cardiomyopathy: the doxorubicin-induced model

  2013cites this paper
• Traitement du lymphome de Hodgkin de l ’ enfant : évolution des protocoles thérapeutiques en Europe Treatment of Hodgkin lymphoma in children : therapeutic trends in Europe

  2013cites this paper
• A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor

  2013cites this paper
• Breast Cancer Pharmacogenetics in the Era of Personalized Medicine

  2012cites this paper
• DNA sequence variants in the carbonyl reductase 1 (cbr1) gene in seven breeds of Canis lupus familiaris.

  2012cites this paper
• CELF 4 Variant and Anthracycline-Related Cardiomyopathy : A Children ' s Oncology Group Genome-Wide Association Study

  year unknowncites this paper